<code id='3441E6B149'></code><style id='3441E6B149'></style>
    • <acronym id='3441E6B149'></acronym>
      <center id='3441E6B149'><center id='3441E6B149'><tfoot id='3441E6B149'></tfoot></center><abbr id='3441E6B149'><dir id='3441E6B149'><tfoot id='3441E6B149'></tfoot><noframes id='3441E6B149'>

    • <optgroup id='3441E6B149'><strike id='3441E6B149'><sup id='3441E6B149'></sup></strike><code id='3441E6B149'></code></optgroup>
        1. <b id='3441E6B149'><label id='3441E6B149'><select id='3441E6B149'><dt id='3441E6B149'><span id='3441E6B149'></span></dt></select></label></b><u id='3441E6B149'></u>
          <i id='3441E6B149'><strike id='3441E6B149'><tt id='3441E6B149'><pre id='3441E6B149'></pre></tt></strike></i>

          Home / entertainment / hotspot

          hotspot


          hotspot

          author:knowledge    Page View:721
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In